Chengdu Shengnuo Biotechnology Co., Ltd. is a high-tech enterprise with the core technology of peptide synthesis and modification
Chengdu Shengnuo Biotechnology Co., Ltd. is a high-tech enterprise with the core technology of peptide synthesis and modification. It has advanced and efficient peptide drug process research and development and large-scale production capacity.
Its main business includes providing pharmaceutical research and customized production services for domestic and foreign pharmaceutical enterprises in the research and development of polypeptide innovative drugs.
Its independent research and development, production and sales are of great significance at home and abroad We have large market capacity and strong competitiveness of polypeptide generic drugs and pharmaceutical products, as well as polypeptide drug production technology transfer services.
In addition,Shengnuo Biotechnology is also engaged in the processing of levosimendan preparations and the production and export of levosimendan API.
It has mastered the large-scale production technology of 15 varieties of API
Shengnuo Biotechnology has selected polypeptide generic drugs with large market capacity and strong market competitiveness at home and abroad for research and development. It has mastered the large-scale production technology of 15 varieties of API.
Among them, 7 varieties have obtained production approval in China, 8 varieties have obtained DMF record (activation status) in the United States, and 7 polypeptide preparation varieties developed by extension have obtained 11 production approval documents in China, The products cover the fields of immune system diseases, tumors, cardiovascular, chronic hepatitis B, diabetes, AIDS and obstetric diseases.
In the future, Shengnuo Biotechnology will seize the development opportunity of rapid growth of peptide generic drug market, continue to deepen the polypeptide drug market, continuously improve the process technology, R & D strength,
marketing management, channel construction and comprehensive management capabilities, improve the overall competitiveness and profitability, grasp the development trend of the global pharmaceutical industry, and take advantage of peptide pharmaceutical research and customized production services, polypeptides We should actively integrate into the pharmaceutical industry chain at home and abroad,
develop more varieties of peptide preparations, and further strengthen the promotion and management level of preparations.
At the same time, Shengnuo Biotechnology will actively lay out the polypeptide innovative medicine business field through cooperative research and development, so as to consolidate the company’s competitive position in the industry.